Cure My Disease

Don't miss your cure!

 Log in / Sign up

New precision therapy trial aims to match salivary gland cancer patients with the right drug

NCT ID NCT06145308

Recruiting now Disease control Sponsor: Peking Union Medical College Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving targeted therapy or chemotherapy based on specific markers (HER2, NTRK, AR, TROP-2) found in a patient's tumor can shrink or control salivary gland cancer. About 39 adults with advanced or recurrent cancer will receive a treatment matched to their marker. The goal is to see how many patients respond and how safe the approach is.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRECISION THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

salivary gland cancer salivary gland carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRECISION THERAPY SALIVARY GLAND CARCINOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fei Ma

    RECRUITING

    Beijing, Beijing Municipality, 100021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.